Centre Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Centre Asset Management, LLC

  • $464 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 17, 2019
SELL
$372.08 - $439.57 $8.14 Million - $9.62 Million
-21,890 Closed
0 $0
Q4 2018

Jan 14, 2019
SELL
$335.82 - $403.04 $221,641 - $266,006
-660 Reduced 2.93%
21,890 $8.18 Million
Q3 2018

Oct 03, 2018
SELL
$351.14 - $408.51 $309,003 - $359,488
-880 Reduced 3.76%
22,550 $9.11 Million
Q2 2018

Aug 06, 2018
BUY
$284.6 - $344.99 $6.67 Million - $8.08 Million
23,430 New
23,430 $8.08 Million

Others Institutions Holding REGN

# of Institutions
1,530
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Centre Asset Management, LLC Portfolio

Follow Centre Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centre Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centre Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email